Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
SBTX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Sales Growth
YoY
Current
Estimates
Return on Equity
QoQ
Institutionnal Ownership
QoQ
Q4.22
+207%
0.72
vs -0.67
Q1.23
N/A
-0.00
vs -0.70
Q2.23
N/A
-0.00
vs -0.55
Q3.23
N/A
-0.00
vs -0.50
Q4.23
N/A
NA
vs 0.72
Q1.24
N/A
NA
vs -0.00
Q2.24
N/A
NA
vs -0.00
Q3.24
N/A
NA
vs -0.00
Q4.24
N/A
NA
vs NA
Q1.25
N/A
NA
vs NA
Q4.22
-275%
-1316000.00 vs 754K
Q1.23
-97%
20K vs 663K
Q2.23
-98%
10K vs 464K
Q3.23
-100%
NA vs 189K
Q4.23
+98%
-30000.00 vs -1316000
Q1.24
-100%
NA vs 20K
Q2.24
+4900%
500K vs 10K
Q3.24
NA
2.1M vs NA
Q4.24
+288703%
86.6M vs -30000
Q1.25
NA
8M vs NA
Q2.23
-7%
-0.07
vs -0.04
Q3.23
-6%
-0.06
vs -0.07
Q4.23
-3%
-0.03
vs -0.06
Q1.24
-5%
-0.05
vs -0.03
Q2.24
-6%
-0.06
vs -0.05
Q3.24
-10%
-0.10
vs -0.06
Q4.24
+19%
0.19
vs -0.10
Q1.25
-15%
-0.15
vs 0.19
Q4.20
62
62
vs NA
NA
Q1.21
67
67
vs 62
8%
Q2.21
77
77
vs 67
15%
Q3.21
76
76
vs 77
-1%
Q4.21
72
72
vs 76
-5%
Q1.22
70
70
vs 72
-3%
Q2.22
69
69
vs 70
-1%
Q3.22
62
62
vs 69
-10%
Relative Strength
SBTX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Hold
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
proactiveinvestors.co.uk
3 hours ago
prnewswire.com
9 hours ago
prnewswire.com
9 hours ago
benzinga.com
11 hours ago
geekwire.com
19 hours ago
pennystocks.com
20 hours ago
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
NASDAQ
0.06 ( 1.03%)
Relative Strenght
Volume Buzz
-32%
Earning Acce
No
Dist 52w H.
22%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How SBTX compares to sector?
SBTX
-109x